GENE ONLINE|News &
Opinion
Blog

2026-06-02|

DXC Technology Launches CoreIgnite Platform to Integrate Fintech Ecosystems with Legacy Banking Systems

by GOAI
Share To

DXC Technology announced the launch of DXC CoreIgnite on Tuesday, a new platform designed to assist financial institutions in integrating and scaling their fintech ecosystems. The service aims to provide banks and other financial organizations with the infrastructure necessary to connect with third-party fintech applications and manage digital services more efficiently.

The platform functions as a middleware solution that bridges the gap between legacy banking systems and modern fintech software. By utilizing DXC CoreIgnite, financial institutions can automate the integration process, which reduces the time required to deploy new digital products. The system also includes tools for managing data security and regulatory compliance as institutions expand their digital service offerings. DXC Technology developed this offering to address the increasing demand for interoperability within the global financial sector, allowing firms to incorporate external innovations into their existing operational frameworks.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: June 2, 2026

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
Insilico Medicine’s ISM8969 Enters Phase 1 Trial, Advancing Brain-Penetrant NLRP3 Inhibitor for Neuroinflammation and CNS Disorders
2026-06-18
PNC Multifamily Capital Launches $251.4 Million Affordable Housing Investment Fund
2026-06-18
ArcelorMittal, thyssenkrupp, and voestalpine Call for EU Emissions Trading System Reforms to Protect Steel Competitiveness
2026-06-18
Hillman Group and Hillwood Begin Construction on Dallas-Fort Worth Multipurpose Facility
2026-06-18
Six Taipei Biotechs Head to BIO 2026 in San Diego, With Precision Medicine, Drug Delivery, and Bioprocess Innovation in Focus
2026-06-18
2026 Tang Prize in Biopharmaceutical Science Honors Three Pioneers of “Living Drug” Immunotherapies
2026-06-17
How One South Korean Hospital Built a Global Reputation Around a $5 Billion Surgical Standard
2026-06-16
Scroll to Top